Les nouvelles insulines : intérêts et inconvénients = New insulins : interests and convenientsSOLA, A; LARGER, E; M'BEMBA, J et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 6, pp 454-460, issn 1624-0693, 7 p.Article

Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesisBÖHM, Anja; STAIGER, Harald; HENNIGE, Anita M et al.Regulatory peptides. 2008, Vol 151, Num 1-3, pp 160-163, issn 0167-0115, 4 p.Article

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metforminKILO, Charles; MEZITIS, Nicholas; JAIN, Rajeev et al.Journal of diabetes and its complications. 2003, Vol 17, Num 6, pp 307-313, issn 1056-8727, 7 p.Article

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptorsHENNIGE, A. M; STRACK, V; METZINGER, E et al.Diabetologia (Berlin). 2005, Vol 48, Num 9, pp 1891-1897, issn 0012-186X, 7 p.Article

Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individualFRANCK, N; STENKULA, K. G; ÖST, A et al.Diabetologia (Berlin). 2007, Vol 50, Num 8, pp 1716-1722, issn 0012-186X, 7 p.Article

The insulin-like growth factor system and cancerLEROITH, Derek; ROBERTS, Charles T.Cancer letters. 2003, Vol 195, Num 2, pp 127-137, issn 0304-3835, 11 p.Article

Similarities and differences between insulin and IGF-I : Structures, receptors, and signalling pathwaysWERNER, Haim; WEINSTEIN, Doron; BENTOV, Itay et al.Archives of physiology and biochemistry. 2008, Vol 114, Num 1, pp 17-22, issn 1381-3455, 6 p.Conference Paper

A randomized trial of the efficacy and acceptability of a pen injectorMURRAY, D. P; KEENAN, P; GAYER, E et al.Diabetic medicine. 1988, Vol 5, Num 8, pp 750-754, issn 0742-3071Article

A novel insulin formulation with a more rapid onset of actionSTEINER, S; HOMPESCH, M; POHL, R et al.Diabetologia (Berlin). 2008, Vol 51, Num 9, pp 1602-1606, issn 0012-186X, 5 p.Article

A COMPARISON OF THE ACTIVITY AND DISPOSAL OF SEMI-SYNTHETIC HUMAN INSULIN AND PORCINE INSULIN IN NORMAL MAN BY THE GLUCOSE CLAMP TECHNIQUEHOME PD; MASSI BENEDETTI M; SHEPHERD GAA et al.1982; DIABETOLOGIA; ISSN 0012-186X; DEU; DA. 1982; VOL. 22; NO 1; PP. 41-45; BIBL. 20 REF.Article

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal InsulinJONASSEN, Ib; HAVELUND, Svend; HOEG-JENSEN, Thomas et al.Pharmaceutical research. 2012, Vol 29, Num 8, pp 2104-2114, issn 0724-8741, 11 p.Article

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in Patients with type 1 diabetesRASKIN, Philip; KLAFF, Leslie; BERGENSTAL, Richard et al.Diabetes care. 2000, Vol 23, Num 11, pp 1666-1671, issn 0149-5992Article

Analogues de l'insuline = Insulin analogsMOSNIER-PUDAR, Helen.MTE. Médecine thérapeutique endocrinologie. 2000, Vol 2, Num 6, pp 540-545, issn 1295-9359Article

Treatment with insulin glargine does not suppress serum IGF-1SLAWIK, M; SCHORIES, M; BUSSE GRAWITZ, A et al.Diabetic medicine. 2006, Vol 23, Num 7, pp 814-817, issn 0742-3071, 4 p.Article

Clinical Effectiveness of Biphasic Insulin Aspart 30:70 Versus Biphasic Human Insulin 30 in UK General Clinical Practice: A Retrospective Database StudyMORGAN, Christopher LI; EVANS, Marc; TOFT, Anders D et al.Clinical therapeutics. 2011, Vol 33, Num 1, pp 27-35, issn 0149-2918, 9 p.Article

A novel one-pot de-blocking and conjugation reaction step leads to process intensification in the manufacture of PEGylated insulin IN-105HAZRA, Partha; CHATTERJEE, Amarnath; SHABANDRI, Qais et al.Bioprocess and biosystems engineering (Print). 2012, Vol 35, Num 8, pp 1333-1341, issn 1615-7591, 9 p.Article

REINHEITSPRUEFUNG VON IM HANDEL BEFINDLICHEN INSULINPRAEPARATEN MIT HILFE DER DISKONTINUIERLICHEN POLYACRYLAMIDGEL-ELEKTROPHORESE = DETERMINATION DU DEGRE DE PURETE DES PREPARATIONS D'INSULINE DU COMMERCE AU MOYEN DE L'ELECTROPHORESE DISCONTINUE SUR GEL DE POLYACRYLAMIDETJWAN OEN TJIOE; WACKER A.1972; KLIN. WSCHR.; DTSCH.; DA. 1972; VOL. 50; NO 18; PP. 882-884; ABS. ANGL.; BIBL. 11REF.Serial Issue

Intensifying Insulin Therapy in Type 2 Diabetes Mellitus: Dosing Options for Insulin Analogue PremixesTIBALDI, Joseph M.Clinical therapeutics. 2011, Vol 33, Num 11, pp 1630-1642, issn 0149-2918, 13 p.Article

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clampHORDERN, S. V. M; WRIGHT, J. E; UMPLEBY, A. M et al.Diabetologia (Berlin). 2005, Vol 48, Num 3, pp 420-426, issn 0012-186X, 7 p.Article

Intranasal insulin improves memory in humans : Superiority of insulin aspartBENEDICT, Christian; HALLSCHMID, Manfred; SCHMITZ, Katrin et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 1, pp 239-243, issn 0893-133X, 5 p.Article

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and Pen devices in adult patients with type 2 diabetes mellitusNISKANEN, Leo; JENSEN, Linda Elise; RASTAM, Jacob et al.Clinical therapeutics. 2004, Vol 26, Num 4, pp 531-540, issn 0149-2918, 10 p.Article

Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glarginePING WU; CHENG JI; MINGLI WANG et al.Annales d'endocrinologie. 2013, Vol 74, Num 1, pp 56-58, issn 0003-4266, 3 p.Article

Insulin X10 revisited: a super-mitogenic insulin analogueHANSEN, B. F; KURTZHALS, P; JENSEN, A. B et al.Diabetologia (Berlin). 2011, Vol 54, Num 9, pp 2226-2231, issn 0012-186X, 6 p.Article

Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin DetemirBRYANT, Ginelle A; MCDANEL, Deanna L; HORNER, Kathleen E et al.Pharmacotherapy. 2013, Vol 33, Num 1, pp 56-62, issn 0277-0008, 7 p.Article

Absorption kinetics of insulin after subcutaneous administrationSØEBORG, The; RASMUSSEN, Christian Hove; MOSEKILDE, Erik et al.European journal of pharmaceutical sciences. 2009, Vol 36, Num 1, pp 78-90, issn 0928-0987, 13 p.Conference Paper